Perspectives on CML management

from Professor Jerry Radich
Fred Hutchinson Cancer Research Center
Seattle, USA

• Assessment of existing therapies in CML including new data on bosunitib in front-line therapy
• Emerging new therapies for CML and how they could come into practice
• Perspectives on treatment discontinuation
• Challenges of CML management in the emerging economic regions: access to treatment and testing

{rscomments off}